The hardest part of Life Science and Biotech marketing isn’t generating interest but staying releveant and visible across the 9 -24 months before your audience buys. That’s exactly where we support you.
A 30 minute diagnostic conversation to identify where your nurture programmes are underperforming.
A pipeline you can explain to the CEO. Leads that move from MQL (Marketing Qualified Lead) to SAL (Sales Accepted Lead) without a battle with sales. Marketing’s contribution to revenue is visible, defensible, and yours.
What’s missing isn’t effort or content volume, but a structured buyer progression system built for the reality of Life Science evaluation cycles; not 30-day campaign bursts.
That’s what Qincade builds.
Leads enter your CRM after a campaign or event, full of potential. Then follow-up becomes sporadic, driven by internal timelines rather than where the buyer actually is in their evaluation. Engagement stall and pipeline cools.
The external problem: strong campaign activity that doesn’t translate to pipeline movement.
The real problem: you’re being asked to show defensible ROI against a nurture model that was never designed for 9-24 month buying cycles with multi-stakeholder committees.
It’s not right that a Head of Marketing running technically credible campaigns, with a CRM full of qualified contacts, has to still spend time defending marketing’s contribution to revenue.
The Lead Nurture Gap – the unmanaged middle phase of the Life Science buyer journey – is the reason that gap exists. And it’s fixable.
We have spent years inside this problem with Life Science, Biotech, MedTech, and diagnostics companies. Our own analysis shows the average time from first content engagement to closed deal can exceed 800 days. Generic nurture sequences don’t account for that.
We’ve built a system that does.
With just the first email, our sales reps have already booked several meetings and sold the first two items!
– Marketing Programmes Lead, MedDevices Instruments Company
We turned to Qincade to help drive our marketing initiatives forward. Together, we executed a seamless, multi-phase campaign with integrated lead nurturing workflows. Qincade’s team was fast, focused, and responsive, making the entire process both efficient and highly effective.
– Director, Demand Generation and Corporate Marketing, Lab Instruments Manufacturing Company
You all have done a fabulous job on this campaign; the sales scripts are great… we’re looking forward to reaping the fruit!
– Sr. Product Marketing Manager, Life Sciences Company
You’ll likely benefit if your organisation matches this profile:
If sales is already complaining about lead quality, that’s the Lead Nurture Gap in plain sight.
Phase 1: Diagnose
Your free 30 minute Readiness Review identifies exactly where buyer progression is breaking down in your current system and benchmarks where you sit across our four-stage maturity model.
Phase 2: Build
We design and implement your lead progression system on top of your existing CRM and MAP. No new platforms. No additional headcount. Typically live within 5-6 weeks of starting to work together.
Phase 3: Progress
Leads start moving. Engagement signals become visible. Sales receives contacts they trust. You have a pipeline you can explain and revenue that you can attribute to marketing motion.
If we don’t believe buyer progression is your real bottleneck, we’ll tell you that in the Readiness Review – directly, with no obligation and no pitch.
The Readiness Review is free, focused, and takes about 30 minutes. You will leave with a clear diagnostic of where your leads are losing momentum, and what a structured progression system would change.
If your nurture model stays as it is – the same sporadic follow-up, the same conversation with sales about lead readiness, the same quarterly review where marketing defends activity rather than demonstrating pipeline – what does that mean for your position in 12 months?
The contacts in your CRM right now are as engaged as they are going to be without structured progression. Every quarter without a system in place, that pipeline conversation becomes harder to have with confidence.
Your next quarterly review starts differently. You open with pipeline movement – not engagement metrics. You show leads that progressed, conversations that started, revenue that traces back to your campaigns.
Sales is engaged because the contacts arriving in their queue are genuinely ready for commercial conversations. Leadership sees marketing as a commercial function, not a cost centre. And you are the person who built the system that made it measurable.
For the marketing leaders we work with, that is not a distant ambition. It is an outcome.
You don’t need more leads. You need a progression system built for the way Life Science buyers actually make decisions.
Book your free Readiness Review; a focused 30 minute conversation to get a clearer picture of where your pipeline stands – and what it would take to move it. No sales pitch. No obligation.
That measured approach is exactly what your buyers take too. Here are the questions we hear most often from Heads of Marketing before they book.
You may be thinking:
Most teams do have bits and pieces of this, but what’s missing is the end‑to‑end system that joins them up:
This isn’t “a few emails stitched together”. It is a complete progression layer over your existing stack that removes guesswork and inconsistency from trying to prove movement of prospects towards MQLs and then SQL stage.
Your team stays focused on running the business. Our system gives them a proven process to plug into.
This methodology is designed to reduce ongoing strain, not increase it.
You will need:
Access to a CRM and some existing marketing content
One commercial sponsor to keep decisions moving
Structured input at key milestones
You will not need:
New tech
New headcount
Daily operational oversight
Most organisations see early engagement and progression signals within 30–60 days, with sales-ready conversations typically visible within 90 days.
The goal is not immediate volume, but measurable movement.
Yes. The work is front‑loaded on our side, with your team involved a few hours a month for decisions and approvals. The goal is to give you time back by reducing manual follow‑up and ad‑hoc firefights.
Yes, because the system surfaces context and signals, not just lead scores.
Sales receives:
Insight into buyer engagement
Mapped progression stages
Defined “ready” triggers
Scripts, content assets and additional commercial nurture cadence as part of the Sales Bridge.
The goal is fewer, better-timed conversations- not more activity.
No. Our progression engine is designed to activate and move the scientific audience you already have, not to generate more top-of-funnel volume.
Most Life Science organisations don’t have a shortage of leads but they do struggle with consistently warming their dormant contacts; clarity over which leads are progressing and how quickly, and creating sales-ready conversations from resultant engagement.
No. Our system works within your existing CRM and automation platforms. It clarifies structure, segmentation, and progression and does not require changing your existing infrastructure.
That’s common and expected.
The first phase of the system focuses on segmentation, ICP clarity, and identifying viable dormant contacts. You don’t need a perfect database to begin and to benefit from this approach.
Yes, particularly for SMEs with:
In many cases, unlocking existing audience value is more cost-effective than scaling paid acquisition
Hi! Let us know how we can help and we’ll respond shortly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Sign up to our list and be first to receive newly-published Qincade resources for science marketers.
